Micah Parsons' trade to the Packers sparks backlash and fan split after his strong performance against the Cowboys in a 40-40 overtime tie.
AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while the company's Enhertu drug shows promising results.
Micah Parsons' trade to the Packers sparks backlash and fan split after his strong performance against the Cowboys in a 40-40 overtime tie.
AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while the company's Enhertu drug shows promising results.
